
1. acs appl mater interfaces. 2017 nov 15;9(45):39152-39164. doi:
10.1021/acsami.7b10796. epub 2017 nov 3.

ovarian cancer therapy vsvmp gene mediated paclitaxel-enhanced
nanoparticle.

long j(1)(2)(3)(4), yang y(1)(3), kang t(1)(3), zhao w(1)(3), cheng h(1)(3), wu
y(1)(3), du t(1)(3), liu b(1)(3), li y(1)(3), luo f(1)(2)(3), gou m(1)(3).

author information: 
(1)state key laboratory biotherapy cancer center, west china hospital,
sichuan university, collaborative innovation center biotherapy, chengdu, 
610041, p.r. china.
(2)department medical oncology, lung cancer center, cancer center, west china 
hospital, medical school, sichuan university , chengdu, sichuan 610041, p. r.
china.
(3)collaborative innovation center biotherapy , chengdu, sichuan 610041, p.
r. china.
(4)department oncology, west china guang'an hospital, sichuan university ,
guang'an, sichuan 638000, p. r. china.

erratum in
    acs appl mater interfaces. 2020 jun 10;12(23):26755.

nanoparticles great promise gene delivery. however, transfection
efficiency nanoparticle-based gene delivery systems always unsatisfied to
meet requirement effective gene therapy. herein, used low-dosage
paclitaxel enhance nanoscaled gene delivery system self-assembled
from n-[1-(2,3-dioleoyloxy)propyl]-n,n,n-trimethylammoniummethyl sulfate and
monomethoxy poly(ethylene glycol)-poly(d,l-lactide) (dpp), creating a
paclitaxel-encapsulated dpp (p-dpp) nanoparticle. encapsulated low-dosage
paclitaxel significantly improved gene delivery efficiency dpp
nanoparticles multiple cancer cells, transfection
efficiency high 92%. p-dpp nanoparticle, vesicular stomatitis
virus matrix protein (vsvmp) could induce cell apoptosis delivered to
treat ovarian cancer. encapsulation paclitaxel dpp nanoparticles
increased expression vsvmp, enhancing vsvmp induce antiproliferation
and apoptosis skov3 ovarian cancer cells. intraperitoneal administration of
p-dpp-delivered vsvmp effectively inhibited intraperitoneal metastasis of
skov3 ovarian cancer, efficient dpp-delivered vsvmp.
moreover, found tumor cell apoptosis induction, tumor cell
proliferation inhibition, tumor angiogenesis suppression involved the
anticancer mechanism nanocomplex. data suggest encapsulation
of low-dosage paclitaxel enhance gene delivery efficiency dpp
nanoparticles multiple cancer cells exert synergistic anticancer
effect vsvmp gene ovarian cancer treatment. vsvmp gene therapy
delivered paclitaxel-enhanced nanoparticle potential application in
ovarian cancer therapy.

doi: 10.1021/acsami.7b10796 
pmid: 28944654  [indexed medline]

